Home/Filings/4/0001437749-20-023031
4//SEC Filing

Kaufman Joel H. 4

Accession 0001437749-20-023031

CIK 0000810509other

Filed

Nov 5, 7:00 PM ET

Accepted

Nov 6, 5:08 PM ET

Size

5.1 KB

Accession

0001437749-20-023031

Insider Transaction Report

Form 4
Period: 2020-11-04
Kaufman Joel H.
Chief Business Officer
Transactions
  • Award

    Stock Option

    2020-11-04$0.00/sh+20,000$2020,000 total
    Exercise: $2.31Exp: 2030-11-04Common Stock (20,000 underlying)
Footnotes (1)
  • [F1]Stock options granted pursuant to the Issuer's Amended and Restated 2014 Stock Incentive Plan, which vest as to one-third (1/3) on each of the first three anniversaries of the date of grant.

Issuer

NAVIDEA BIOPHARMACEUTICALS, INC.

CIK 0000810509

Entity typeother

Related Parties

1
  • filerCIK 0001831425

Filing Metadata

Form type
4
Filed
Nov 5, 7:00 PM ET
Accepted
Nov 6, 5:08 PM ET
Size
5.1 KB